Wedge Capital Management’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.76M Sell
109,110
-21,750
-17% -$495K 0.05% 277
2026
Q1
$2.8M Buy
130,860
+6,810
+5% +$142K 0.05% 275
2025
Q4
$2.65M Sell
124,050
-14,178
-10% -$291K 0.05% 302
2025
Q3
$2.32M Buy
+138,228
New +$2.07M 0.04% 325
2024
Q1
Sell
-81,988
Closed -$762K 513
2023
Q4
$762K Buy
81,988
+32,831
+67% +$340K 0.01% 389
2023
Q3
$625K Sell
49,157
-93,908
-66% -$1.29M 0.01% 391
2023
Q2
$2.03M Buy
143,065
+131,042
+1,090% +$1.84M 0.03% 367
2023
Q1
$179K Buy
+12,023
New +$182K ﹤0.01% 415
2021
Q1
Sell
-10,658
Closed -$262K 567
2020
Q4
$262K Sell
10,658
-819
-7% -$15.4K ﹤0.01% 485
2020
Q3
$187K Sell
11,477
-6,179
-35% -$115K ﹤0.01% 499
2020
Q2
$302K Sell
17,656
-7,426
-30% -$110K ﹤0.01% 422
2020
Q1
$292K Buy
25,082
+6,389
+34% +$132K 0.01% 402
2019
Q4
$519K Buy
18,693
+677
+4% +$17K 0.01% 391
2019
Q3
$408K Sell
18,016
-15,352
-46% -$350K ﹤0.01% 434
2019
Q2
$842K Sell
33,368
-983,843
-97% -$26.4M 0.01% 363
2019
Q1
$27.6M Buy
1,017,211
+18,153
+2% +$609K 0.32% 104
2018
Q4
$33M Sell
999,058
-79,814
-7% -$3.21M 0.41% 82
2018
Q3
$50.3M Sell
1,078,872
-189,776
-15% -$8.71M 0.48% 58
2018
Q2
$54.9M Sell
1,268,648
-691,337
-35% -$33.1M 0.54% 55
2018
Q1
$109M Sell
1,959,985
-137,890
-7% -$7.56M 1.05% 20
2017
Q4
$112M Sell
2,097,875
-3,157
-0.2% -$149K 1.01% 24
2017
Q3
$90.6M Sell
2,101,032
-21,480
-1% -$1.02M 0.84% 29
2017
Q2
$128M Buy
2,122,512
+182,025
+9% +$10.8M 1.23% 14
2017
Q1
$135M Sell
1,940,487
-24,164
-1% -$1.68M 1.29% 11
2016
Q4
$131M Buy
1,964,651
+43,980
+2% +$2.86M 1.27% 12
2016
Q3
$127M Buy
1,920,671
+403,140
+27% +$27.6M 1.28% 12
2016
Q2
$110M Buy
+1,517,531
New +$104M 1.14% 20

Other funds holding MD

Wedge Capital Management's MD Position: Q2 2026 in Review

Wedge Capital Management reduced its Pediatrix Medical (MD) stake by 17% in Q2 2026, selling an estimated $495K and leaving 109,110 shares worth $2.76M. The position accounts for 0.05% of the portfolio, ranked #277.

Wedge Capital Management first reported a position in MD in Q2 2016 and has held it in 27 quarters since. The position peaked at $135M in Q1 2017. 305 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Wedge Capital Management held 109,110 shares of Pediatrix Medical worth $2.76M as of Q2 2026.
  • Wedge Capital Management sold 21,750 Pediatrix Medical shares in Q2 2026, an estimated $495K.
  • Pediatrix Medical made up 0.05% of Wedge Capital Management's portfolio in Q2 2026, its #277 holding.
  • Wedge Capital Management first reported a position in Pediatrix Medical in Q2 2016 and has held it in 27 quarters since.
  • Wedge Capital Management's Pediatrix Medical position peaked at $135M in Q1 2017.
  • 305 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Wedge Capital Management's 13F filing for Q2 2026, filed 10 Jul 2026.